Member Info for whimax

Excellent post Greend100, and you are spot on about delivery method and autoimmune response. The fact that the Trial is Covid related is MASSIVE tho, simply because if it’s successful (and I agree with you in thinking that it will be) it will propel Tiziana into the spotlight. Foralumab as a treatment for Covid was never going to be a huge earner in itself, but by go it will put of the map, and multiple radars.

With regards your question about cost of production, I seem to remember in one of the videos either GC or SK said that because of the large reduction in quantities required (i.e. targeting specific areas of the body rather flooding the whole body intravenously and effectively wasting huge quantities of the MAb) that Foralumab would be relatively cheap to produce per dose required. I may be mistaken on the that point, but I’m sure I’ll be corrected if I am.

It’s only 3 weeks ago that AP said this in the RNS about EOI letters.

“ Today's announcement is also further evidence of the Company delivering on what it said it would do, namely, advancing the commerciality of the Lixus asset and generating value to shareholders in the process. This is an important first step towards securing financing for the project and we look forward to updating our stakeholders on further developments during the remainder of 2020."

That, to me, does NOT suggest he has any plans to raise funds at this point in time, no matter what the share price is this year. To say only 3 weeks ago that they will update Shareholders “during the remainder of 2020” then hit them with a fund raise, would be absolutely ridiculous imo. They have also talked about putting “fizzle in the share price”. Again, I’d be surprised if that was by way of a placing lol.

IMO the BoD will be aiming for something to be ‘firmed up’ or ‘tangible’ before year end, to at least double the SP from this level, and lay a solid foundation before even thinking about going to the market for additional funds.

I notice your “profound knowledge” doesn’t extend to grammar - that would be “too” Oblivious lol.

Why don’t we all just wait and see CE, instead of reposting the same comment over and over again lol.

So, as of now, U.K. and Nasdaq share prices are aligned for the first time in several weeks.

Interesting to see what happens next.

“Rather ironically, every time i post a moan, the price ticks up....”

Lol. Pity it doesn’t work when Chab posts a moan, we’d be at about £1.50 lol :-))

fleur.wood@nuformix.com

Thanks Soup. I’ll use that one next time.

Chablard, have you written/emailed the company?

I actually emailed them on Monday with a long list of questions based on RNS’s and comments made by BoD members going back to last year, which I feel we probably should had answers to, or updates on.

I only sent my email through the website “contact us” link and needless to say I have not received an acknowledgment or answer, but I suggest if people are not happy, they should do the same. If anyone has a personal email address then that would probably be preferable, but I couldn’t find one for anyone.. The more they get, the more likely they are to do something about communication imo.

The product mentioned in this report IS NOT EVEN CLOSE to being anything like Tiziana’s product!!

The product in this article claims to reduce the likelihood of catching COVID 19 (which may or may not be the case to any given degree) Foralumab is a TREATMENT for Covid 19. The ONLY similarity (if you can even call it that) is that they are both products are taken nasally.

Good god, give me strength lol.

I posted this on 3rd November. 50/50 for me which gets sold first, TILS or AccuStem, imo. Either could happen in next 3 months.

======================
What if it’s the other way round?03 Nov 2020 12:18

Just a thought/starter for 10, but what if the company that’s under more threat from a buy out is TILS and NOT AccuStem??

I have always thought StemPrinter was being demerged in order to facilitate a clean buy out/sale and to achieve the best possible price, but what if it’s Tiziana that’s being courted (you know, the company with the 5 NDA’s) and AccuStem is just being Demerged as GC & SK’s next project.

I’m not saying anything is imminent, but IF Brazil trials are successful, Big Pharma will be all over TILS like a nasty rash.

Thanks guys.

Should have known! Lol
Fkwits!!

There’s a guy on Stockwits called DoUrOwnDD who just posted “ TLSA
notice how this doesn't go down, that's the fund managers back stopping every dip, get use this until the 21st”.
Again, my account has been locked, so would someone mind asking him to expand on that, AND what the relevance is of the “21st”, please.

Thanks in advance.

P.s. Can someone (who’s not been locked out Stockwits) post this video over there please.

Thanks for posting Davethehands. Hadn’t seen it.

Defo worth a watch. PR machine picking up again.

Those were Options belderino.

Lol

So no fund raise at this level imo.

Any more word from “your guy” about that RNS lol?

We’ll have to agree to disagree JohnHenry.

I accept there can be a difference is SP between 2 exchanges but not 30% (Nasdaq down 1% currently to our 6.5% today alone). As far as I understand it ADRs are converted into Ordinary Shares or vice versa on any given day, so someone is making a killing somewhere along the line at the moment, and have been for the past 2 weeks.

Not sure why volume is relevant JH to be honest? The gap is increasing daily at the moment. What’s the point in a duel listing if volume on one exchange doesn’t affect the price on the other and vice versa.

I finally got my head around the disparity during the Demerger when it was explained that ADR conversation had halted until US had reached ex entitlement date, but that’s not an excuse any longer. People in the US are currently able to sell their TILS/TLSA shares for 30% more than we have been able to in the UK for the best part of 2 weeks. I understand they are currently paying 30% more if buying, however that may also be part of the problem.

Yep, 25%+ difference between US & UK. Staggering. And the gap is widening on a daily basis.

I emailed Dr Kunwar this morning. Will update if I hear anything back.